Peptides vs Cash Cat

Cash Cat (CASHCAT) is 855.6× the size of Peptides (PEPTIDES) by market capitalisation. Over the past 30 days, CASHCAT is ahead by 7.2 percentage points (PEPTIDES -43.9% against CASHCAT -36.7%). Their daily returns move barely in opposite directions (correlation -0.18 across 23 shared trading days). CASHCAT has been the more volatile of the two, at 261% annualised against PEPTIDES's 149%.

Correlation: -0.18
Size ratio: 1 : 855.6
Ahead over 30 days: CASHCAT

PeptidesPEPTIDES

$0.000127

24h: -0.66%
Market cap: $126,789
Volume 24h: $264
Volatility (ann.): 149%

Cash CatCASHCAT

$0.109832

24h: +7.85%
Market cap: $108.48M
Volume 24h: $16.64M
Volatility (ann.): 261%

PEPTIDES 0.1%Share of the two combined market caps99.9% CASHCAT

Performance

PEPTIDESCASHCAT

7 days+16.33%+3.53%PEPTIDES
30 days-43.89%-36.68%CASHCAT

Correlation

-0.18over 23 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	PEPTIDES	CASHCAT
Max drawdown (400d)	-53.4%	-69.6%
Risk-adjusted return (90d)	-0.24	-0.03

Relative strength over 90 days: PEPTIDES outperformed CASHCAT by 19.9% — measured on the PEPTIDES/CASHCAT ratio, so it holds regardless of market direction.

Peptides →Cash Cat →